All Stories

  1. Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology

    Article • Nature Communications, August 2023, Springer Science + Business Media

    Gerco den Hartog

  2. Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

    Article • ESMO Open, August 2023, Elsevier

    Gerco den Hartog

  3. Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study

    Article • International Journal of Infectious Diseases, August 2023, Elsevier

    Gerco den Hartog

  4. Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study

    Article • EClinicalMedicine, July 2023, Elsevier

    Gerco den Hartog

  5. Age-specific severity of SARS-CoV-2 in February 2020 – June 2021 in the Netherlands

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  6. Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection in the Netherlands, September to December 2022

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  7. The effect of previous SARS-CoV-2 infection and COVID-19 vaccination on SARS-CoV-2 Omicron infection and relation with serological response – a prospective cohort study

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  8. Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from 12 July 2021 to 6 June 2022: a prospective cohort study

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  9. Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study

    Article • Annals of Internal Medicine, December 2022, American College of Physicians

    Gerco den Hartog

  10. Reduced Antibody Acquisition with Increasing Age following Vaccination with BNT162b2: Results from Two Longitudinal Cohort Studies in The Netherlands

    Article • Vaccines, September 2022, MDPI AG

    Gerco den Hartog

  11. Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome

    Article • The Journal of Infectious Diseases, June 2022, Oxford University Press (OUP)

    Gerco den Hartog

  12. Design and baseline description of an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands - The VAccine Study COvid-19 (VASCO)

    Article • May 2022, Research Square

    Gerco den Hartog

  13. Three-dose mRNA-1273 vaccination schedule: sufficient antibody response in majority of immunocompromised hematology patients

    Article • April 2022, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  14. Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

    Article • Blood Advances, March 2022, American Society of Hematology

    Gerco den Hartog

  15. Chemokine profiling in children and adults with symptomatic and asymptomatic respiratory viral infections

    Article • Journal of Infection, December 2021, Elsevier

    Gerco den Hartog

  16. Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study

    Article • International Journal of Infectious Diseases, October 2021, Elsevier

    Gerco den Hartog

  17. Children and adults with mild COVID-19 symptoms develop memory T cell immunity to SARS-CoV-2

    Article • September 2021, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  18. Tolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA-1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  19. SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees

    Article • Science Immunology, May 2021, American Association for the Advancement of Science

    Professor (Associate) Bart L. Haagmans, Gerco den Hartog

  20. Asthma-Associated Long TSLP Inhibits the Production of IgA

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Gerco den Hartog

  21. Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study

    Article • Clinical Infectious Diseases, February 2021, Oxford University Press (OUP)

    Gerco den Hartog

  22. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro

    Article • Viruses, February 2021, MDPI AG

    Gerco den Hartog

  23. Berberine and obatoclax inhibit SARS-CoV-2 replication in primary human nasal epithelial cells in vitro

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  24. Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave

    Article • Journal of Epidemiology & Community Health, November 2020, BMJ

    Gerco den Hartog

  25. Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens

    Article • Processes, November 2020, MDPI AG

    Gerco den Hartog

  26. Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years

    Article • The Journal of Infectious Diseases, September 2020, Oxford University Press (OUP)

    Gerco den Hartog

  27. SARS-CoV-2–Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence

    Article • The Journal of Infectious Diseases, August 2020, Oxford University Press (OUP)

    Gerco den Hartog

  28. SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Gerco den Hartog

  29. Immune surveillance for vaccine-preventable diseases

    Article • Expert Review of Vaccines, March 2020, Taylor & Francis

    Gerco den Hartog

  30. Bordetella pertussis Induces Interferon Gamma Production by Natural Killer Cells, Resulting in Chemoattraction by Respiratory Epithelial Cells

    Article • The Journal of Infectious Diseases, March 2020, Oxford University Press (OUP)

    Gerco den Hartog

  31. The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV

    Article • Journal of Immunological Methods, November 2018, Elsevier

    Gerco den Hartog

  32. BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood B cells

    Article • European Journal of Immunology, October 2017, Wiley

    Gerco den Hartog

  33. Oxidative Stress Resulting From Helicobacter pylori Infection Contributes to Gastric Carcinogenesis

    Article • Cellular and Molecular Gastroenterology and Hepatology, May 2017, Elsevier

    Gerco den Hartog

  34. Intestinal immune maturation is accompanied by temporal changes in the composition of the microbiota

    Article • Beneficial Microbes, November 2016, Wageningen Academic Publishers

    Gerco den Hartog

  35. An alternative inhibition method for determining cross-reactive allergens

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2016, De Gruyter

    Gerco den Hartog

  36. 5 Regulation of Rac1 and Reactive Oxygen Species Production in Response to Helicobacter pylori Infection of Gastric Epithelium

    Article • Gastroenterology, April 2016, Elsevier

    Gerco den Hartog

  37. 973 Human Intestinal Epithelial Host Defense Against Pathogenic Bacterial Infections is Regulated by AP Endonuclease 1 (APE1/Ref-1)

    Article • Gastroenterology, April 2016, Elsevier

    Gerco den Hartog

  38. House dust mite-specific IgA2 is associated with protection against eczema in allergic patients

    Article • Allergy, January 2016, Wiley

    Gerco den Hartog

  39. Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia

    Article • PLoS Pathogens, January 2016, PLOS

    Dr. Asima Bhattacharyya, Gerco den Hartog

  40. Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk

    Article • PLoS ONE, November 2014, PLOS

    Gerco den Hartog

  41. Ontogeny of the avian intestinal immunoglobulin repertoire: Modification in CDR3 length and conserved VH-pseudogene usage

    Article • Molecular Immunology, December 2013, Elsevier

    Gerco den Hartog

  42. The Mucosal Factors Retinoic Acid and TGF-β1 Induce Phenotypically and Functionally Distinct Dendritic Cell Types

    Article • International Archives of Allergy and Immunology, January 2013, Karger Publishers

    Gerco den Hartog

  43. Modulation of Human Immune Responses by Bovine Interleukin-10

    Article • PLoS ONE, March 2011, PLOS

    Gerco den Hartog

  44. Successive immunoglobulin and cytokine expression in the small intestine of juvenile chicken

    Article • Developmental & Comparative Immunology, December 2010, Elsevier

    Gerco den Hartog

  45. 4 Wat gebeurt er bij een allergie?

    Article • January 2010, Springer Science + Business Media

    Gerco den Hartog